Cargando…

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy

Background. Interventions such as opiate substitution therapy (OST) and high-coverage needle and syringe programs (HCNSP) cannot substantially reduce hepatitis C virus (HCV) prevalence among people who inject drugs (PWID). HCV antiviral treatment may prevent onward transmission. We project the impac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, Natasha K., Hickman, Matthew, Hutchinson, Sharon J., Goldberg, David J., Vickerman, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722076/ https://www.ncbi.nlm.nih.gov/pubmed/23884064 http://dx.doi.org/10.1093/cid/cit296

Ejemplares similares

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
por: Platt, Lucy, et al.
Publicado: (2017)

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis
por: Platt, Lucy, et al.
Publicado: (2017)

Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis
por: MacArthur, Georgie J, et al.
Publicado: (2012)

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
por: Stone, Jack, et al.
Publicado: (2017)

The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review
por: Gillies, Michelle, et al.
Publicado: (2010)

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
por: Martin, Natasha K, et al.
Publicado: (2013)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
por: Martin, Natasha K., et al.
Publicado: (2016)

The cost-effectiveness of an HCV outreach intervention for at-risk populations in London, UK
por: Ward, Zoe, et al.
Publicado: (2019)

Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis
por: Artenie, Adelina, et al.
Publicado: (2023)

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
por: Martin, Natasha K, et al.
Publicado: (2013)

Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database
por: Cornish, Rosie, et al.
Publicado: (2010)

Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection
por: Skočibušić, Siniša, et al.
Publicado: (2022)

Impact of current and scaled‐up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?
por: Ward, Zoe, et al.
Publicado: (2018)

Injection partnership characteristics and HCV status associations with syringe and equipment sharing among people who inject drugs
por: Mackesy-Amiti, Mary Ellen, et al.
Publicado: (2023)

Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan
por: Zule, William A., et al.
Publicado: (2015)

Effectiveness of needle and syringe Programmes in people who inject drugs – An overview of systematic reviews
por: Fernandes, Ricardo M, et al.
Publicado: (2017)

Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky
por: Stone, Jack, et al.
Publicado: (2020)

Hypo-Substitute for Opiates
Publicado: (1899)

Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment
por: Kimber, Jo, et al.
Publicado: (2010)

Evaluating the impact of global fund withdrawal on needle and syringe provision, cost and use among people who inject drugs in Tijuana, Mexico: a costing analysis
por: Cepeda, Javier A, et al.
Publicado: (2019)

Sharing of Needles and Syringes among Men Who Inject Drugs: HIV Risk in Northwest Bangladesh
por: Pasa, M. Kamal, et al.
Publicado: (2016)

Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection
por: Chaillon, Antoine, et al.
Publicado: (2019)

HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco
por: Page, Kimberly, et al.
Publicado: (2019)

Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights
por: Martin, Natasha K., et al.
Publicado: (2016)

The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
por: Stone, Jack, et al.
Publicado: (2016)

Laboratory Study on Injection Force Measurement on Syringe and Needle Combinations
por: Prasetyono, Theddeus Octavianus Hari, et al.
Publicado: (2019)

HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England
por: Romo, Eric, et al.
Publicado: (2023)

Organic Collaborative Research Partnership Building: Researchers, Needle and Syringe Program Providers, and People Who Inject Drugs
por: Resiak, Danielle, et al.
Publicado: (2021)

Quality-adjusted life years among people who inject drugs in a needle syringe program in Sweden
por: Kåberg, Martin, et al.
Publicado: (2022)

The Biomechanics and Optimization of the Needle-Syringe System for Injecting Triamcinolone Acetonide into Keloids
por: Vo, Anthony, et al.
Publicado: (2016)

Options for reducing HIV transmission related to the dead space in needles and syringes
por: Zule, William A., et al.
Publicado: (2018)

The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study
por: Stone, Jack, et al.
Publicado: (2022)

Optimal Control of Hepatitis C Antiviral Treatment Programme Delivery for Prevention amongst a Population of Injecting Drug Users
por: Martin, Natasha K., et al.
Publicado: (2011)

The effects of scale on the costs of targeted HIV prevention interventions among female and male sex workers, men who have sex with men and transgenders in India
por: Chandrashekar, S, et al.
Publicado: (2010)

Modelling the impact and cost‐effectiveness of non‐governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine
por: Stone, Jack, et al.
Publicado: (2023)

Improving the quality of needle and syringe programmes: an overlooked strategy for preventing hepatitis C among people who inject drugs
por: Leicht, Astrid
Publicado: (2014)

Injecting drug users in Scotland, 2006: Listing, number, demography, and opiate-related death-rates
por: King, Ruth, et al.
Publicado: (2013)

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
por: Harris, R. J., et al.
Publicado: (2016)

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact
por: Martin, N K, et al.
Publicado: (2015)

Understanding the Reasons for Sharing Syringes or Needles to Inject Drugs: Conventional Content Analysis
por: Faghir-Gangi, Monireh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qor8kniadhe6rruds3seunba34